cushieblog.com
Clinical Trial: Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
Sponsor: Cedars-Sinai Medical Center Information provided by (Responsible Party): Shlomo Melmed, MD, Cedars-Sinai Medical Center Brief Summary: This phase 2 multicenter, open-label clinical trial w…